By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Enteris Biopharma 

83 Fulton Street

Boonton  New Jersey  07005  U.S.A.
Phone: 973-453-3530 Fax: 973-585-1229


Drug Delivery

Company News
Enteris Biopharma Oral Formulation Progresses Into Phase 2 Study With Cara Therapeutics, Inc. (CARA)' CR845 7/14/2015 11:21:12 AM
Enteris Biopharma Launches Contract Manufacturing Within 32,000 Square Foot, FDA Inspected And Cgmp Compliant Facility 2/10/2015 7:59:12 AM
Enteris Biopharma's Formulation Technology Enables Oral Delivery Of Cara Therapeutics, Inc. (CARA)' CR845 Peptide For Acute And Chronic Pain In Phase 1a / 1b Trial 12/9/2014 8:35:48 AM
Enteris Biopharma Oral Peptide Delivery Technology Enables Key Clinical Milestone For Acute And Chronic Pain Drug 6/20/2014 6:30:55 AM
Enteris Biopharma To Present At Biotech Showcaseā„¢ 2014 1/9/2014 8:13:23 AM
Enteris Biopharma Forms Scientific Advisory Board to Enhance Leadership In Oral Delivery Of Peptide And Small Molecule Drugs 12/3/2013 11:53:15 AM
Enteris Biopharma and Nordic Bioscience A/S's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform 9/30/2013 10:03:48 AM
Enteris Biopharma Emerges From the Ashes of Unigene Laboratories, Inc. (UGNE), Hunts for Deals 8/28/2013 7:08:35 AM
Enteris Biopharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand "Peptelligenceā„¢ Partnering" Program 8/20/2013 6:53:29 AM
Enteris Biopharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics 8/5/2013 10:22:59 AM